Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus
Comparison of dendritic cell-mediated immune responses among canine malignant cells
Contribution of selected vitamins and trace elements to immune function
Dendritic cells reconstituted with a human heparanase gene induce potent cytotoxic T-cell responses against gastric tumor cells in vitro
Levels of antigen processing machinery components in dendritic cells generated for vaccination of HIV-1+ subjects
Localized hyperthermia combined with intratumoral dendritic cells induces systemic antitumor immunity
Weekly systemic cisplatin plus locoregional hyperthermia: an effective treatment for patients with recurrent cervical carcinoma in a previously irradiated area
Robust CD4+ and CD8+ T cell responses to SIV using mRNA-transfected DC expressing autologous viral Ag
Immunity of unloaded dendritic cells in lung melanoma of mice
Review: dendritic cell-based vaccine in the treatment of patients with advanced melanoma
A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model
Immunotherapy for prostate cancer using antigen-loaded antigen-presenting cells: APC8015 (Provenge)
Immunotherapy with dendritic cells for prostate cancer
Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy
Benefits of superficial hyperthermia treatment planning: five case studies
Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: preliminary results of a prospective phase II study
Dendritic cell vaccination
Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma
Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma
Development of vaccines for high-risk ductal carcinoma in situ of the breast